ImmunoCellular Therapeutics (NYSE: IMUC) announced the establishment of an agreement with the European Organisation for Research and Treatment of Cancer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE